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Abstract
Platelets are central players in inflammation and are an important component of the innate immune response. The ability to
visualize platelets within the live host is essential to understanding their role in these processes. Past approaches have
involved adoptive transfer of labelled platelets, non-specific dyes, or the use of fluorescent antibodies to tag platelets in
vivo. Often, these techniques result in either the activation of the platelet, or blockade of specific platelet receptors. In this
report, we describe two new methods for intravital visualization of platelet biology, intravenous administration of labelled
anti-CD49b, which labels all platelets, and CD41-YFP transgenic mice, in which a percentage of platelets express YFP. Both
approaches label endogenous platelets and allow for their visualization using spinning-disk confocal fluorescent
microscopy. Following LPS-induced inflammation, we were able to measure a significant increase in both the number and
size of platelet aggregates observed within the vasculature of a number of different tissues. Real-time observation of these
platelet aggregates reveals them to be large, dynamic structures that are continually expanding and sloughing-off into
circulation. Using these techniques, we describe for the first time, platelet recruitment to, and behaviour within numerous
tissues of the mouse, both under control conditions and following LPS induced inflammation.
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Introduction
The interface between innate and adaptive immunity is
critically central to the host immune response. In recent years,
platelets have emerged as an important component of this
interface, shaping both the innate and adaptive immune responses
[1–4]. Although primarily associated with hemostasis, platelets
express a wide variety of immune receptors (TLRs, CD14, CD40,
FcR) and release numerous immune effectors upon activation
(IL1b, TGFb, RANTES, MCP-1, CD40L) [1]. Together, these
receptors and molecules allow platelets to modulate leukocyte
recruitment [5], activation and effector functions such as
phagocytosis, cytotoxicity and extracellular DNA release (NETs)
[6], key events at the crossroads between innate and adaptive
immunity. A summary from the Fourth Annual Platelet Collo-
quium concluded that platelets can recruit cells to sites of vascular
injury, release pro- and anti-inflammatory factors, produce
microparticles, and can induce thrombin generation [7]. These
processes have been shown to be critical in the induction or
progression of diseases such as atherosclerosis, sepsis, hepatitis,
vascular restenosis, acute lung injury and transplant rejection.
Although some information about platelet localization can be
gained from immunohistochemical staining of tissue sections or
radioisotope labelling of adoptively transferred platelets [2,8], the
limitation of these techniques is the inability to study the dynamic
interactions between platelets, leukocytes, and the vasculature.
The development of intravital microscopy, and more recently,
intravital spinning-disk confocal microscopy, has allowed for the
observation of cellular behaviour within the tissue microenviron-
ment of live animals. The capacity of spinning-disk confocal
microscopy to capture individual frames of multiple fluorescence
wavelengths in rapid succession, something that is not possible
with conventional scanning-confocal microscopy, affords the
ability to image rapidly moving particles, such as platelets, and
makes this technology ideal for the study of platelet dynamics in
vivo. The difficulty in studying platelets however, has been the
identification of markers that can be used in vivo to specifically label
platelets without affecting their behaviour.
Currently, most studies have utilized one of two general
approaches; either intravenous administration of a non-specific
fluorescent dye such as rhodamine 6-G [9,10] or the adoptive
transfer of platelets isolated from a donor animal, labelled in vitro
with a fluorescent dye, and injected into a recipient animal [8,11].
These techniques allow for the visualization of platelets within the
live animal, and have provided insight into platelet recruitment and
adherence; however, they too have limitations. Although rhoda-
mine 6-G efficiently labels platelets in vivo and allows for
visualization of platelet-vessel wall interactions, due to its non-
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cells, including neutrophils and monocytes, key targets for platelet
interactions. This makes it impossible to distinguish aggregates of
platelets from leukocytes at sites of inflammation or to visualize
platelets directly associated withrhodamine6-G labelled leukocytes.
In contrast, ex vivo staining of purified platelets results in specific
labelling and allows for the study of platelet interactions with other
cells, however, only a small percentage of the platelets in the
recipient animal are labelled following adoptive transfer (endog-
enous platelets remain unlabelled). This limits the ability to
measure total platelet recruitment, aggregate size or to visualize
platelet-platelet interactions. Additionally, platelets are easily
activated by shear stress and temperature fluctuation [12,13].
Thus one has to pay particular attention to the platelet isolation,
labelling and transfusion to ensure that the adoptively transferred
platelets are not activated and that their behaviour upon transfer
mirrors that of endogenous platelets. Not trivial is the fact that
such experiments require the killing of substantial numbers of
additional animals in order to obtain platelets for transfer.
More recent approaches have focused on monoclonal antibody
(mAb) labelling of platelets in vivo. Early attempts to use mAb
against the pan-platelet marker CD41 were not optimal [14].
Although this approach allowed for the visualization of platelets in
vivo [15,16], mAb directed against CD41 have been reported to
inhibit more than 80% of cellular adhesion to fibrinogen [17], an
important molecule in platelet and cellular recruitment to sites of
inflammation, and platelet aggregation [14,18]. Other experi-
ments have used an mAb directed against the platelet surface
receptor GPIbb [19], and although this mAb is able to label
platelets in vivo, it blocks the ability of platelets to bind von
Willebrand factor [20] and possibly Mac-1, important mediators
of platelet adhesion and neutrophil-platelet interactions [21]. The
undesired effects of anti-CD41 and anti-GPIbb antibodies make
these approaches to platelet labelling less than ideal for the study of
platelet responses to inflammatory stimuli.
In our efforts to find a better surface marker to facilitate platelet
labelling, without blocking platelet function, we have identified
CD49b as a suitable target molecule. Fluorescently conjugated
antibodies against this marker readily label platelets in vivo with no
observable effect on platelet behaviour. Additionally, we have
utilized a transgenic mouse expressing yellow fluorescent protein
(YFP) under the control of the CD41 promoter [22] to further
characterize platelet dynamics and to validate the results obtained
by in vivo Ab labelling by CD49b. Finally, we highlight examples of
how these approaches, combined with spinning-disk confocal
microscopy and 3D reconstruction capabilities, reveal new and
important data about platelet function in vivo.
Results
In vivo labelling of mouse platelets with anti-CD49b
In blood, CD49b is expressed on NK cells, a subset of NKT
cells and on platelets [23–25]. Due to this restricted expression, we
decided to test the suitability of this molecule as a marker for
platelets in vivo. Flow cytometric analysis of blood platelets
demonstrates the mAb HMa2 directed against CD49b stains
nearly all platelets as identified by the pan-platelet marker CD41
(Fig. 1A). This staining appears to be bright, stable and uniform,
with a single population of CD49b+ platelets. These results
identify this marker as a potential candidate for in vivo labelling of
platelets for intravital microscopy applications. Intravenous (i.v.)
administration of 1.6 mg of PE-conjugated anti-CD49b rapidly
labelled a large number of particles within the liver vasculature
that were several fold smaller than leukocytes (Fig. 1Bi, Movie
S1). These particles were measured to have a diameter of
2.8060.37 mm, which fall into the expected size range of mouse
platelets [26]. Unexpectedly, many of these particles were
observed to briefly interact with the sinusoid wall or with the
few neutrophils present in an untreated liver. Although brief
interactions could be observed, these particles almost never
remained adherent but rather appear to freely circulate through
the liver sinusoids (Fig. 1Bii, Movie S2).
To ensure the particle-endothelial interactions observed in
control mice were not the result of surgical manipulation of the
tissue, we examined particle behaviour within the ear microvas-
culature, a tissue that requires no surgical preparation prior to
visualization of the blood vessels. Once again, no adherent, and a
few interacting particles are seen under resting conditions (Fig.
S1, Movie S3). These results indicate that the observed particle-
Figure 1. In vivo labelling of mouse platelets by intravenous
injection of the anti-CD49b antibody HMa2. Anti-CD49b uni-
formly labels all CD41+ platelets in mouse blood (A). Intravenous
injection of PE-conjugated anti-CD49b (red) labels circulating platelets
within the mouse liver (Bi –106objective, Bii –206objective) and pre-
treatment of mice with anti-thrombocyte serum (Ci –106objective, Cii
–206 objective) results in the loss of CD49b+ particles confirming
particles labelled by CD49b are indeed platelets. Neutrophils labelled
with Alexa Fluor 647-conjugated anti-Gr-1 (blue). All scale bars, 20 mm.
doi:10.1371/journal.pone.0025109.g001
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surgical manipulation of the tissue.
To further establish the identity of these particles as platelets,
mice were pretreated with anti-thrombocyte serum for 20 h prior
to intravital microscopy. In these platelet-depleted animals there
was an absence of labelled particles following injection of PE-
conjugated anti-CD49b (Fig. 1Ci, Cii, Movie S4). The lack of
labelling in thrombocyte depleted mice, together with the flow
cytometric analysis of CD41 and CD49b co-staining of mouse
peripheral blood, positively identifies the labelled particles
observed by intravital microscopy as platelets. Mice receiving
intravenous anti-CD49b do not present any of the adverse health
effects observed using anti-CD41 antibodies [14] and have
remained stable for more than three hours, allowing for the
intravital observation of platelets throughout this timeframe
(unpublished observations).
It should be noted that this staining also labels NK cells within
the tissue and blood (Fig. S2). These cells are extremely rare,
fewer than 10/low power field of view in the mouse liver, despite
this tissue being a main target and resident site for NK cells. They
are much larger than a platelet, and their staining is fainter than
that of the platelets, allowing for direct observation of platelet-NK
cell interactions if needed. As such, these cells do not interfere with
intravital platelet analysis. No iNKT cells were labelled with this
approach. Treatment of Cxcr6
gfp/+ mice, whose iNKT cells are
GFP-positive, failed to result in dual labelling of these cells (data
not shown).
Use of anti-CD49b for the intravital study of platelet
recruitment to the mouse liver
Treatment of mice with LPS has been reported to induce the
recruitment of neutrophils and platelets to various tissues [6]. In
sharp contrast to the liver of control animals (Fig. 2Ai–iv),
intravital analysis of livers from mice treated with 1 mg/kg LPS
i.v. for 4 h clearly demonstrates profound neutrophil recruitment
(Fig. 2Bi, Bii). Furthermore, analysis of peripheral blood in these
mice reveals a drop in the circulating platelet count (Fig. S3).
Intravenous administration of PE-conjugated anti-CD49b allows,
for the first time, the direct intravital visualization of endogenous
platelet recruitment to this tissue. Platelets are readily observed to
be interacting primarily with the large number of neutrophils
already adherent within the liver. Many fewer interactions are
seen between platelets and the liver sinusoids and almost no
interaction between circulating neutrophils and adherent platelets
can be observed. Many of the recruited platelets form aggregates,
often the same size as, or larger than, the adherent neutrophils
(Fig. 2Bi, Movie S5). Extended focus images generated from
stacks of multiple xy planes at higher magnification reveals many
of these aggregates are associated with neutrophils (Fig. 2Bii),
forming from an initial adherence of platelets to a neutrophil
followed by platelet-platelet interactions facilitating the expansion
of the growing aggregate. Often, aggregates are seen to be
spanning between two proximal neutrophils and appear to greatly
reduce the blood flow in a number of liver sinusoids. By rendering
3D models of these z stacks with the Volocity software package we
are able to visualize these platelet-neutrophil interactions from a
number of different perspectives (Fig. 2Biii, Movie S6). Closer
inspection of representative neutrophils from LPS treated mice
illustrates the interaction between the large platelet aggregates and
the adherent neutrophils (Fig. 2 Biv). These platelet aggregates
cover large portions of the neutrophil surface and appear to ‘‘wrap
around’’ the neutrophil. Through the generation of these z stacks,
and the subsequent 3D images, we are able to determine these
platelet aggregates are directly associated with the adherent
neutrophils, an observation that would not be possible through the
imaging of individual static sections. These findings are consistent
with the observation that neutropenia precedes thrombocytopenia
in this model of inflammation [2]. Unlike previous reports using
other models of inflammation, we rarely see platelets first binding
to endothelium followed by neutrophil recruitment to these
adherent platelets [27–29].
In contrast, the few adherent neutrophils present in the liver of
untreated mice are largely free of platelet interactions (Fig. 2Aiii,
Aiv (representative 3D models)). In the few examples of neutrophil-
platelet interactions in untreated mice, we do not see substantial
platelet-platelet interactions and as suchthere is a failure to generate
larger platelet aggregates. It is important to note our in vivo platelet
labelling excludes platelet activation due to platelet isolation or in
vitro labelling procedures.
Visualization of platelets within the mouse liver in response to
LPS treatment allows for the characterization of receptors and
adhesion molecules involved in platelet recruitment. Past reports
have implicated the adhesion molecule CD18 in the binding of
platelets to neutrophils [18,30–32], dendritic cells [33], and T cells
[34], although to date, the effect of CD18 blockade on platelet
recruitment has not been visualized in vivo. As previously reported
by our group [35,36], pre-treatment of mice with a blocking Ab
directed against CD18 has no effect on neutrophil recruitment to
the liver in response to LPS (Fig. 2Ci). By contrast, CD18
blockade had a dramatic effect on platelet recruitment to the
inflamed liver (Fig. 2Ci–Civ). Although individual platelets
appeared to be recruited independent of CD18, large aggregates
failed to form in mice treated with anti-CD18 blocking antibody.
Furthermore, because i.v. administration of anti-CD49b labels
all platelets, it is possible to measure the size of the numerous
platelet aggregates. The area of staining corresponding to each
platelet aggregate was measured and the number of aggregates
equal to, or greater than, specific size thresholds were enumerated.
We observed a significant increase in both the total number of
recruited platelets and the size of platelet aggregates within the
livers of LPS treated mice (Fig. 2Di, Dii). This platelet
recruitment and aggregation was significantly inhibited by the
pre-treatment of mice with a blocking Ab against CD18.
The ability of CD18 blockade to inhibit platelet aggregation is
particularly interesting given the fact that platelets have not been
reported to express this molecule. One possible mechanism to
explain this observation might involve the formation of micropar-
ticles. LPS treatment has been reported to result in the generation
of neutrophil, endothelial and platelet derived microparticles.
These microparticles are formed from the plasma membrane and
can express cell surface markers and adhesion molecules derived
from the cell from which they were released [37–39]. These
particles have been reported to express CD18 and might facilitate
platelet aggregation by bridging between ligands on individual
platelets. Flow cytometric analysis of platelets from untreated and
LPS-treated mice failed to detect any association between platelets
and either neutrophil (GR1+) or Kupffer cell (F4/80+) derived
membranes (Fig. S4A, B). Furthermore, expression of CD18 was
not detected on platelets obtained from untreated or LPS-treated
mice, further ruling out the association of platelets with CD18+
microparticles (Fig. S4C).
As we were unable to detect CD18 expression by platelets, it is
most likely this molecule is expressed by other cells involved in
platelet aggregation. In fact, CD18 is highly expressed by both
neutrophils and Kupffer cells [40–43], and platelets express a
number of ligands for b2 integrins (ICAM-2, Gp1ba, JAM-C)
[30,33]. These observations suggest CD18 expressing leukocytes
within the liver vasculature bind platelets and initiate aggregation.
Intravital Visualization of Platelets
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cells dramatically inhibits platelet aggregation, indicating these
cells are essential to the process (Fig. S5). Therefore, it is likely
that circulating platelets must touch-down on, and anchor to, a
neutrophil or Kupffer cell as a first step towards the generation of
larger platelet aggregates.
Through the use of intravital microscopy we are able to
visualize the behaviour of platelets within the liver sinusoids and
their interactions with adherent neutrophils. It is clear from these
studies that the platelet aggregates that form in response to LPS
are not static entities, but rather, are dynamic structures,
continually expanding and sloughing off (Fig. 2E, Movie S7
(white arrow identifies a large platelet aggregate tearing off of a
neutrophil)). These platelet aggregates often appear to ‘‘flow’’
across the surface of an adherent neutrophil (Movie S6, S7). In
addition to platelet aggregates associated with adherent neutro-
phils, we are also able to observe circulating platelet-neutrophils
aggregates (Fig S6, Movie S8). Neutrophils, covered with large
platelet aggregates can be seen flowing through the liver sinusoids,
with little interaction between the neutrophil and the vessel walls.
These observations would not be possible with other techniques
such as staining of tissue sections, intravital observation of
adoptively transferred platelets, or in vivo labelling of platelets with
rhodamine 6-G and are essential to our understanding of platelets
in the host immune response.
Use of CD41-YFP
ki/+ mice for the intravital study of
platelet recruitment to the mouse liver
The generation and characterization of CD41-YFP
ki/+ mice
has been previously reported [22], although, to date these mice
have not been used for the intravital study of platelet behaviour. In
these mice, a percentage of platelets express YFP (Fig. S7) and
thus are visible using fluorescence microscopy without the need to
add an exogenous label. As such, these mice can be used to
confirm that the platelet adhesion observed in Fig. 2 is
independent of the labelling of platelets by anti-CD49b. As the
percentage of YFP-labelled platelets varies significantly from
mouse to mouse (from less than 10% to more than 40%) [22],
all animals must be pre-screened by flow cytometry to ensure
individuals in the control and treated groups have comparable
Figure 2. Quantification of platelet aggregation in the livers of
mice treated with intravenous LPS using PE-conjugated anti-
CD49b. Intravital microscopy of livers from untreated mice (Ai–Aiv),
LPS treated mice (Bi–Biv) and mice pre-treated with an anti-CD18
blocking mAb followed by LPS (Ci–Civ). Representative fields of view at
low power (106objective) magnification (Ai, Bi, Ci) illustrating platelet
aggregation in response to LPS and inhibition of aggregation following
pre-treatment with an anti-CD18 blocking Ab. Platelets labelled with PE-
conjugated anti-CD49b (red); neutrophils labelled with Alexa Fluor 647-
conjugated anti-Gr-1 (blue). Arrows denote large platelet aggregates.
Higher power (206objective) extended focus images (Aii, Bii, Cii) and
3D opacity models (Aiii, Biii, Ciii) rendered from 29–30 z planes
illustrating the extent of platelet aggregation in LPS treated mice. All
scale bars, 20 mm; grid 25.7 mm. Select models of neutrophil-platelet
aggregates (Aiv, Biv, Civ) extracted (as indicated by the white arrows)
and enlarged from panel (iii). (Di, Dii) Quantification of the number of
platelet aggregates equal to, or larger than the indicated sizes.
*** p,0.001, * p,0.05, n.s. not significant (E) Time lapse images of
neutrophil-platelet interactions illustrating the dynamic nature of the
platelet aggregates within the liver. Long white arrow identifies a large
platelet aggregate tearing off of an adherent neutrophil, short yellow
arrow indicates direction of blood flow within the sinusoid. Sequential
images represent 2.3 s intervals. Scale bar, 20 mm.
doi:10.1371/journal.pone.0025109.g002
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average of 21.6%65.9% YFP positive platelets.
Intravital observation of YFP+ platelets in the liver sinusoids of
untreated mice reveals little platelet adhesion or aggregation
(Fig. 3Ai, 3Aii), an observation similar to what was seen when
anti-CD49b was used to label the platelets. Some YFP+ platelets
appear to interact with the sinusoidal walls or adherent
neutrophils, touching down briefly, but then quickly releasing
and re-entering the blood flow (Movie S9), a behaviour that is
again consistent with that observed when platelets were labelled
with anti-CD49b. In contrast, livers of mice treated with LPS
demonstrate pronounced platelet recruitment (Fig. 3Bi, 3Bii),
where YFP+ platelets are seen to be associated with the sinusoid
walls and even more so with the numerous recruited neutrophils
(Movie S10). It is important to note that only approximately 20%
of platelets are visible in these mice and, as such, visualization of
platelet-platelet interactions and platelet aggregation is limited.
Furthermore, because not all platelets are labelled, it is impossible
to measure the total size of platelet aggregates in this model. One
advantage of these mice, however, is individual platelets can be
visualized more easily, thus making it easier to study platelet
behaviour on the level of the single platelet.
Quantification of the number of adherent (stationary for $30 s)
and the number of interacting platelets (present in a field of view
for $30 s but not stationary) demonstrates significant increases in
LPS-treated mice when compared to untreated mice (Fig. 3C).
Furthermore, we can characterize the interactions of individual
platelets with adherent neutrophils in the liver. Following LPS
treatment, the average number of YFP+ platelets bound by each
neutrophil (platelets that remain adherent for $30 s) increased
significantly as compared to untreated mice (Fig. 3D). Moreover,
the percentage of neutrophils that were not associated with YFP+
platelets was significantly reduced and the percentage of
neutrophils binding three or more YFP+ platelets increased
significantly following treatment with LPS (Fig. 3E). These
CD41-YFP
ki/+ data support the observations made using anti-
CD49b where a 3-4 fold increase in the total number of platelet
aggregates ($10 mm
2, Fig. 2Di), many of which are adherent to
neutrophils, is seen in the livers of mice treated with LPS.
A more detailed understanding of platelet recruitment to the
liver following LPS exposure can be obtained through the use of
additional stains to identify other cell populations. Intravenous
injection of PE-conjugated anti-F4/80 rapidly labels Kupffer cells,
the liver resident macrophage population (Fig. 4A, B), and allows
for visualization of platelet interactions with these cells. In livers of
LPS treated CD41-YFP
ki/+ mice co-stained for neutrophils and
Kupffer cells, platelets can be seen to adhere to neutrophils,
Kupffer cells, regions of the hepatic sinusoids devoid of neutrophils
and Kupffer cells, and to areas of co-localization of neutrophils
and Kupffer cells, suggesting no single cell type is responsible for
all platelet adhesion in the liver (Fig. 4Aiv, Biv, Movie S11).
Enumeration of bound platelets demonstrates a significant
increase in adherence to neutrophils, Kupffer cells, and to liver
sinusoidal endothelium following LPS exposure (Fig. 4C). Inter-
estingly, a far greater number of platelets are found to be
associated with Kupffer cells than are seen associated with
neutrophils, suggesting that Kupffer cells play a central role in
platelet aggregation within the liver, an observation to our
knowledge never previously noted. Although this finding is novel,
it is not entirely surprising given that Kupffer cells occupy a
greater area than do neutrophils in any given field of view (Fig.
S8), and as such have the capacity to recruit a greater number of
platelets.
Taken together, the data generated in the CD41-YFP
ki/+ mice
support the observations made using anti-CD49b to visualize
platelets and validate this molecule for in vivo labelling of the total
peripheral platelet population in mice. Both approaches for
visualizing platelets resulted in an approximately 4-fold increase
in platelet adhesion ($10 mm
2, Fig. 2Di, 3C) with many of the
recruited platelets appearing to be associated with adherent
neutrophils within the liver. Furthermore, as platelet recruitment
to the liver was comparable between the two models, one can
Figure 3. Quantification of platelet recruitment to livers of
mice treated with intravenous LPS using CD41-YFP
ki/+ mice.
Representative fields of view of livers from untreated (Ai, Aii) and LPS
treated (Bi, Bii) CD41-YFP
ki/+ mice. Neutrophils are labelled with Alexa
Fluor 647-conjugated anti-Gr-1 (blue); YFP+ platelets and liver
autofluorescence (green). All scale bars, 20 mm. (C) Quantification of
the number of adherent (stationary for $30 s) and interacting (present
in the field of view for but not stationary for $30 s) YFP+ platelets per
field of view of liver in untreated and LPS treated CD41-YFP
ki/+ mice. (D)
Average number of YFP+ platelets adherent to each neutrophil within
the livers of untreated and LPS treated CD41-YFP
ki/+ mice. (E)
Percentage of neutrophils with zero or with three or more adherent
platelets within the livers of untreated and LPS treated CD41-YFP
ki/+
mice. *** p,0.001.
doi:10.1371/journal.pone.0025109.g003
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enhances platelet recruitment to the liver in response to LPS
challenge and allows for the observation of normal platelet
behaviour in vivo.
Visualization of platelet recruitment in other tissues
using anti-CD49b
We have demonstrated the novel use of PE-conjugated anti-
CD49b to readily visualize platelet dynamics in the mouse liver;
however, this technique can also be applied to other tissues.
Intravital visualization of the mouse brain microvasculature using
anti-PECAM-1 reveals no platelet aggregation, and rare platelet-
endothelial interactions under resting conditions (Fig. 5A, Movie
S12).
In contrast to untreated mice, neutrophil and platelet
recruitment can be readily observed in the brain 4 h following
LPS treatment (Fig. 5B, Movie S13). Platelets can be seen
adhering to primarily to adherent neutrophils with a few
interactions with the vascular endothelium. Almost all of these
interactions occur in the postcapillary venules of the brain with
little recruitment seen in brain arterioles. Similar to what was
observed in the liver, these platelet interactions appear to be very
dynamic, with platelets adhering to neutrophils or endothelium
and forming unstable aggregates that, after a period of time,
slough off into the circulation.
Platelets can also be observed in muscle microvasculature using
PE-conjugated anti-CD49b. Intravital visualization of postcapil-
lary venules in the cremaster muscle using anti-PECAM-1 reveals
little platelet adherence in untreated animals, although some
platelets can be seen interacting with the vascular endothelium,
appearing to touch-down and then quickly release (Fig. 6A,
Movie S14). Following LPS exposure, however, dramatic
neutrophil and platelet recruitment can be observed (Fig. 6B,
Movie S15). Again, platelets are seen to interact with, and adhere
to, both the vessel endothelium and neutrophils in a dynamic
fashion. These videos also demonstrate that platelet interaction
with neutrophils does not require the neutrophil to be adherent.
In some instances, neutrophils covered in platelets can be observed
in circulation and seen rolling on the cremaster vascular
endothelium.
Discussion
Platelets are emerging as central players in both innate and
adaptive immunity [1,3,4,6]. As such, a more in depth knowledge
of their role in inflammation, immune cell recruitment and cellular
activation is critical to our understanding of these processes.
Intravital microscopy can reveal elegant details about the dynamic
interactions between platelets and their surrounding environment,
information that is not possible to obtain from other techniques.
Although recent advances have been made in the ability to label
and visualize platelets in the living animal, isolation of platelets for
labelling or injection of mAb against specific platelet receptors
such as CD41 have a number of limitations.
Figure 4. Characterization of platelet binding in the livers of
mice treated with intravenous LPS using CD41-YFP
ki/+ mice.
Representative fields of view of livers from untreated (A) and LPS (B)
treated CD41-YFP
ki/+ mice. Visualization of YFP+ platelets and liver
autofluorescence (Ai, Bi), neutrophils labelled with Alexa Fluor 647-
conjugated anti-Gr-1 (Aii, Bii), Kupffer cells labelled with PE-conjugated
anti-F4/80 (Aiii, Biii), and overlay of fluorescent channels (Aiv, Biv).
Examples of platelets interacting with the liver sinusoid away from
neutrophils or Kupffer cells (long white arrows), platelets interacting
with neutrophils (short white arrows), platelets interacting with Kupffer
cells (short yellow arrows), and platelets appearing to interact with both
Kupffer cells and neutrophils (long yellow arrows). All scale bars, 20 mm.
(C) Quantification of the number of YFP+ platelets bound to
neutrophils, Kupffer cells and liver sinusoids per field of view within
livers of untreated and LPS treated CD41-YFP
ki/+ mice. *** p,0.001,
** p,0.01.
doi:10.1371/journal.pone.0025109.g004
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total peripheral platelet population and can facilitate the
visualization of platelets by intravital microscopy. The use of the
anti-CD49b mAb HMa2 for the labelling of platelets has several
advantages over previous approaches. First, i.v. administration of
anti-CD49b, unlike CD41 [14], does not induce an adverse
systemic response. Second, HMa2 is widely available and can be
ordered pre-conjugated to a number of different fluorophores.
Third, this technique can be used to visualize platelets in mice with
various genetic backgrounds and gene knockouts whereas models
Figure 6. Intravital visualization of platelets labelled with PE-
conjugated anti-CD49b within the mouse cremaster muscle.
Spinning-disk confocal-microscopic imaging of cremaster postcapillary
venules in untreated (A) and LPS treated mice (B). Visualization of
endothelium with Alexa Fluor 488-conjugated anti-CD31 (Ai, Bi),
neutrophils labelled with Alexa Fluor 647-conjugated anti-Gr-1 (Aii,
Bii), platelets stained with PE-conjugated anti-CD49b (Aiii, Biii), and
multi-channel overlay (Aiv, Biv). A small number of platelets are seen
to interact with the postcapillary endothelium in the cremaster muscle
under basal conditions (A). Neutrophil recruitment and platelet
interactions increase dramatically in the vessels of the cremaster
muscle following LPS treatment (B). Small arrows identify platelets
interacting with neutrophils; large arrows identify platelets interacting
with the endothelium. All scale bars, 20 mm.
doi:10.1371/journal.pone.0025109.g006
Figure 5. Intravital visualization of platelets labelled with PE-
conjugated anti-CD49b within the mouse brain. Spinning-disk
confocal-microscopic imaging of brain pial arterioles and postcapillary
venules in untreated (A) and LPS treated mice (B). Visualization of
endothelium with Alexa Fluor 488-conjugated anti-CD31 (Ai, Bi),
neutrophils labelled with Alexa Fluor 647-conjugated anti-Gr-1 (Aii,
Bii), platelets stained with PE-conjugated anti-CD49b (Aiii, Biii), and
multi-channel overlay (Aiv, Biv). There was a marked absence of
platelet or neutrophil adhesion in brain pial vessels of untreated mice
(A), however, profound neutrophil and platelet recruitment within brain
venules (faint CD31 staining), but not in brain pial arterioles (bright
CD31 staining), following LPS treatment (B). Small arrows identify
platelets interacting with neutrophils; large arrows identify platelets
interacting with the endothelium. All scale bars, 20 mm.
doi:10.1371/journal.pone.0025109.g005
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ki/+ mice need to be bred onto other genetic
backgrounds. Finally, HMa2 does not interfere with the ability of
platelets to bind fibrinogen [44], an important property if one is to
examine the role of platelets in inflammation. Using this
technique, we have been able to study in vivo, as one example,
the formation of platelet aggregates in response to LPS exposure.
Furthermore, as all platelets are labelled using this procedure, it is
possible to measure the size of individual platelet aggregates and to
visualize platelet-platelet interactions. These observations are not
possible if only a fraction of platelets are labelled, as is the case in
experiments using adoptive transfer of labelled platelets.
In addition to visualizing platelets with mAb, we have utilized
the CD41-YFP
ki/+ mouse [22] to validate our approach of
labelling platelets with anti-CD49b. The behaviour of platelets in
LPS treated CD41-YFP
ki/+ mice, a model where no exogenous
label is added to the platelets, parallels that observed with anti-
CD49b in LPS treated C57BL/6 mice. As a result we have been
able to confirm that labelling of platelets with anti-CD49b does not
alter their response to an inflammatory stimulus and validates the
use of this mAb for the visualization of platelet dynamics in vivo.I n
CD41-YFP
ki/+ mice, only a percentage of platelets express YFP
and thus are visible by intravital fluorescence microscopy.
Whereas it is not possible to measure the size of a given platelet
aggregate in this model, it is possible to observe individual platelets
within aggregates. This allows for study of individual platelet
behaviour and adhesion, even in areas of massive inflammation.
Through the use of additional in vivo labels, such as anti-Gr-1 and
anti-F4/80, we are able to observe and track the interactions
between platelets, neutrophils and Kupffer cells within the LPS
challenged liver. Interestingly, Kupffer cells bound the most
platelets although the purpose platelet adherence to these cells
remains to be determined.
Using these two techniques, we have for the first time, observed
in vivo platelets under both control, and inflammatory conditions.
From these experiments we have identified several novel aspects of
platelet behaviour. In some tissues, such as the liver, platelets are
observed to frequently interact with the blood vessel walls under
basal conditions, briefly touching down and then releasing back
into circulation, appearing to probe or patrol the unactivated
endothelium. In contrast, other tissues, such as the brain,
demonstrate much less frequent platelet-endothelial cell interac-
tions under control conditions. Following LPS stimulation, we
observe large numbers of platelets interacting with adherent
neutrophils, appearing to both roll across the surface of the
neutrophil and to firmly adhere to these cells. Platelets are also
observed to directly interact with other cell types, such as Kupffer
cells and endothelial cells. In contrast to previous reports, few
neutrophils are observed being recruited to adherent platelets.
Furthermore, following LPS stimulation, platelets are observed to
form large, dynamic aggregates that are continually expanding
and sloughing off into circulation. These aggregates are dependent
on CD18-mediated adhesion and blockade of this integrin
completely disrupts the formation of these structures. Finally, in
addition to interactions with adherent cells, platelets were also
observed to interact with circulating neutrophils following LPS
treatment. These circulating platelet-neutrophil aggregates are
similar to platelet-leukocyte aggregates (PLA) frequently found in
the blood of septic patients [45–48], and are thought to contribute
to disease pathogenesis, potentially through the occlusion of organ
microvasculature. This work represents the first in vivo observation
of these platelet-neutrophil aggregates and future studies will be
aimed at understanding the formation and role of these aggregates
in severe inflammatory disease.
Through the use of multiple techniques for platelet labelling, we
report that anti-CD49b provides an accurate and comprehensive
picture of platelet dynamics in a variety of tissues. We were able to
measure the number and size of platelet aggregates, to track
individual platelet behaviour, and to study the numerous
interactions between a given platelet and its surrounding
environment. Although anti-CD49b may have some effect on
platelet binding to collagen, and as such may not be appropriate
for some models of platelet recruitment, the ability to label and
visualize platelets in vivo using this antibody, without affecting the
ability of platelets to bind important mediators such as fibrinogen
or von Willebrand factor, affords many new opportunities for the
study of cellular recruitment to sites of inflammation, platelet
interactions with bacteria or parasites, platelet-neutrophil-endo-
thelium interactions, and the role of platelets in modulating
cellular activation, such as the production of NETs by neutrophils
[6]. These new experimental possibilities will greatly expand our
knowledge of these processes and will help facilitate the
development of novel treatment approaches and strategies for
numerous conditions involving platelet activation or dysfunction.
Methods
Ethics Statement
All experiments involving animals were approved by the
University of Calgary Animal Care Committee (Protocol #
MO8131) and conform to the guidelines established by the
Canadian Council for Animal Care. For all experiments, mice
were anesthetised by intra-peritoneal (i.p.) injection of 200 mg/kg
ketamine (Bayer Inc Animal Health, Toronto, Ontario, Canada)
and 10 mg/kg xylazine (Bimeda-MTC, Cambridge, Ontario,
Canada).
Mice
Wildtype C57BL/6 (The Jackson Laboratory, Bar Harbor, ME)
and CD41-YFP
ki/+ (a generous gift from Dr. Kelly McNagny,
University of British Columbia, Vancouver, British Columbia,
Canada) colonies were maintained in specific-pathogen free
facilities at the University of Calgary. At the time of use, animals
were between 7 and 10 weeks of age and weighed 20–30 g.
Antibodies and Treatments
Phycoerythrin (PE)-conjugated and allophycocyanin (APC)-
conjugated Armenian hamster anti-mouse CD49b (clone
HMa2), PE-conjugated rat anti-mouse CD41 (clone MWReg30),
and FITC-conjugated goat-anti-rat IgG were purchased from BD
Biosciences Pharmingen (San Diego, CA). PE-conjugated rat anti-
mouse F4/80 (clone BM8), unconjugated and Alexa Fluor 647-
conjugated rat anti-mouse Ly-6G (GR1) (clone RB6-8C5),
unconjugated rat anti-mouse CD18 (clone GAME-46), unconju-
gated rat anti-mouse PECAM-1 (clone 390), and unconjugated rat
IgG1 isotype control antibodies were purchased from eBioscience
(San Diego, CA). For intravital microscopy, rat anti-mouse
PECAM-1 mAb was conjugated to Alexa Fluor 488 using a
protein labelling kit as per the manufacturer’s instructions
(Invitrogen, Eugene, OR). In vivo blockade of CD18 was achieved
by i.v. administration of 100 mg of anti-CD18 mAb 20 min prior
to LPS treatment. Platelet depletion was performed by i.p.
injection of 100 ml of anti-thrombocyte serum (Cedarlane,
Burlington, Ontario, Canada). Highly purified lipopolysaccharide
(LPS) (Escherichia coli O111:B4) was purchased from Calbiochem
(EMD Sciences, San Diego, CA). For liver and brain studies, mice
were treated with 1 mg/kg LPS i.v. 4 h prior to intravital analysis;
in cremaster studies, mice received 0.5 mg/kg LPS in 200 mlo f
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depletion was performed by i.p. injection of 200 mg of unconju-
gated GR-1 24 h prior to LPS treatment. Kupffer cell depletion
was achieved by i.v. injection of 200 ml of clodronate liposomes
30 h prior to LPS treatment as previously described [49,50].
Flow Cytometry
Approximately 900 ml of blood was collected from anesthetised
mice via cardiac puncture into a syringe containing 100 ml of acid-
citrate dextrose. For platelets, blood was centrifuged for 10 min at
1006g at room temperature in a desktop microfuge and the
platelet rich plasma was collected. Collected plasma was
centrifuged a second time at 1006g for 3 min to remove any
contaminating red blood cells. Platelet rich plasma was collected
into a new microfuge tube and stained with mAb diluted in FACS
wash buffer (PBS containing 1 mM EDTA, 2% FBS) for 30 min
on ice. Platelets were washed with cold FACS wash buffer, pelleted
by centrifugation, resuspended in 100 ml of cold FACS wash
buffer. For leukocytes, whole blood was lysed in a 36volume of
ACK Lysing Buffer (Lonza, Walkersville, MD), pelleted by
centrifugation, washed with cold FACS wash buffer. Cells were
stained with mAb diluted in FACS wash buffer for 30 min on ice,
washed and resuspended in cold FACS wash buffer. Analysis was
performed on either a FACScan (Beckton Dickinson, Mississauga,
Ontario, Canada) or Attune Acoustic Focusing Cytometer (Life
Technologies, Carlsbad, California).
Platelet Counts
Approximately 450 ml of blood was collected from anesthetised
animals via cardiac puncture into a syringe containing 50 mlo f
0.5 M EDTA. Blood was transferred to EDTA coated microtainer
tubes (Beckton Dickinson). Samples were transported to Calgary
Lab Services for haematological analysis.
Spinning-disk Confocal Intravital Microscopy (IVM)
Two different spinning-disk confocal microscopes were used in
these studies.
Liver microscopy was performed using an Olympus IX81
inverted microscope (Olympus, Center Valley, PA), equipped with
an Olympus focus drive and a motorized stage (Applied Scientific
Instrumentation, Eugene, OR). This microscope is fitted with a
motorized objective turret equipped with UPLANSAPO 106/
0.40 and UPLANSAPO 206/0.70 objective lenses and is
mounted to an optical table (Newport, Irvine, CA) to minimize
vibration when imaging. This microscope is coupled to a confocal
light path (WaveFx; Quorum Technologies, Guelph, Ontario,
Canada) based on a modified Yokogawa CSU-10 head (Yokogawa
Electric Corporation, Tokyo, Japan).
Brain, cremaster, and ear microscopy was performed using an
Olympus BX51WI upright microscope (Olympus), equipped with
a Ludl focus drive and a motorized stage (Applied Scientific
Instrumentation). This microscope is mounted to a optical
breadboard (Newport) to minimize vibration, fitted with UP-
LANFL N 106/0.30W and XLUMPPlanFI 206/0.95W objec-
tive lenses, and is coupled to a confocal light path (WaveFx;
Quorum Technologies) based on a modified Yokogawa CSU-10
head (Yokogawa Electric Corporation).
For both microscopes, each of 491-, 561-, and 642-nm
excitation laser wavelengths (Cobolt, Stockholm, Sweden) were
sequentially controlled and merged into a single optic cable using
an LMM5 laser merge module (Spectral Applied Research,
Richmond Hill, Ontario, Canada). Fluorescence was visualized
through one of ET 525/50M (green channel), FF 593/40 (red
channel), or ET 700/75M (far red channel) band pass emission
filters (Semrock, Rochester, NY) driven by a MAC 6000 Modular
Automation Controller (Ludi Electronic Products, Ltd.,
Hawthorne, NY) and detected with a 5126512 pixels back-
thinned EMCCD camera (C9100-13, Hamamatsu, Bridgewater,
NJ). Volocity Acquisition software (V5.2.1 – Inverted; V4.3.2 –
Upright) (Improvision Inc., Lexington, MA) was used to drive the
confocal microscope. Image acquisition settings varied according
to the microscope used and the tissue visualized. Typical laser
power, exposure time and sensitivity settings are as follows, Liver
(inverted); green channel (autofluorescence –80%, 415 ms, 215;
CD41-YFP –75%, 425 ms, 250), red channel (CD49b –90%,
150 ms, 210; F4/80–90%, 100 ms, 210), far red channel (Ly-6G –
80%, 300 ms, 200), Brain (upright); green channel (PECAM-1–
95%, 300 ms, 240), red channel (CD49b –100%, 70 ms, 240), far
red channel (Ly-6C –100%, 300 ms, 250), Cremaster and Ear
(upright); green channel (PECAM-1–80%, 500 ms, 115), red
channel (CD49b –95%, 500 ms, 120), far red channel (Ly-6G –
80%, 500 ms, 120). Green, red, and far red channels were overlaid
using brightest point settings before exporting in .tiff or .avi
format.
Preparation of the Mouse Liver for Intravital Microscopy
Intravital microscopy of the mouse liver was performed as
previously described [51]. Briefly, the tail vein of anesthetised mice
was cannulated to permit the delivery of fluorescently labelled Ab
and for maintenance of anesthetic. Mouse body temperature was
maintained using an infrared heat lamp. A midline incision
followed by a lateral incision along the costal margin to the
midaxillary line was performed to expose the liver. The mouse was
place in a right lateral position and the ligaments attaching the
liver to the diaphragm and the stomach were cut allowing the liver
to be externalized onto a glass coverslip on the inverted
microscope stage. Exposed abdominal tissues were covered with
saline-soaked gauze to prevent dehydration. The liver was draped
with a saline soaked KimWipe to avoid tissue dehydration and to
help restrict movement of the tissue on the slide.
Preparation of the mouse brain for IVM
The tail vein of an anesthetised mouse was cannulated to permit
intravenous delivery of antibodies and additional anesthetic, if
required. To isolate movement, the animal’s head was held in a
stereotaxic board. Skin covering the parietal bone of the mouse
skull was reflected and the left parietal bone was carefully thinned
using a high-speed drill (Fine Science Tools, North Vancouver,
British Columbia, Canada) to allow for transillumination. Care
was taken as to not open the cranial vault to ensure physiological
pressures and blood flow were maintained. Intravital visualization
of leukocyte biology within the pial microvasculature was
performed through this thinned skull tissue using an upright
microscope.
Preparation of the mouse cremaster for IVM
The mouse cremaster muscle was used to study neutrophil
recruitment as previously described [52]. In brief, the jugular vein
of an anesthetised mouse was cannulated to permit intravenous
delivery of antibodies and additional anaesthetic, if required. Mice
were placed on a special cremaster preparation board and body
temperature was maintained through a heat pad. An incision was
made in the scrotal skin to expose the left cremaster muscle, which
was then carefully dissected free of the associated fascia. The
cremaster muscle was cut longitudinally with a cautery. The
testicle and the epididymis were separated from the underlying
muscle and were moved into the abdominal cavity. The muscle
was held flat on an optically clear viewing pedestal and was
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superfused with 37uC warmed bicarbonate-buffered saline, pH 7.4
and covered with a coverslip. Intravital visualization of leukocyte
biology was performed using an upright microscope.
Preparation of the mouse ear for IVM
The jugular vein of an anesthetised mouse was cannulated to
permit intravenous delivery of antibodies and additional anaes-
thetic, if required. The mouse was placed on a heat pad to
maintain the body temperature and the dorsal hair from the right
ear was gently removed using depilatory cream (Nair; Church &
Dwight Co., Inc, Princeton, NJ) without causing any irritation.
The ear was carefully flattened out on an elevated preparation
board, superfused with 37uC warmed bicarbonate-buffered saline,
pH 7.4, and held in place with a coverslip applied on the dorsal
side of the ear. Intravital visualization of leukocyte biology was
performed using an upright microscope.
Image Processing
Still images were exported from the Volocity (Improvision)
acquisition software as .tif images. Images for platelet aggregate
quantification were imported directly into ImageJ. Display items
were processed using Photoshop (Adobe, San Jose, CA) to adjust
the minimum threshold values for each of the fluorescence
channels. The same threshold values were applied to images from
all treatment groups within a single experiment. Videos underwent
contrast enhancement within the Volocity software package,
adjusting the Black Point for each fluorescence channel. Again,
the same settings were applied to the videos of all treatment groups
within a given experiment. Videos were exported as .avi files and
were converted to an appropriate size, resolution, and frame rate
using Microsoft Movie Maker (Microsoft Canada, Mississauga,
Ontario, Canada) and Prism Video Converter Software (NCH
Software Inc., Greenwood Village CO).
3D Model Generation
Z Stacks of xy planes (0.5 mm intervals) were imaged using an
inverted spinning-disk confocal microscope using either the ASI
focus drive (Applied Scientific Instrumentation) or Olympus focus
drive (Olympus). 3D isosurface models of platelet aggregates were
rendered within the Volocity software package (Improvision) using
the 3D-opacity option. The same Black Level settings for each
fluorescence channel were applied to all images. For 3D videos,
individual frames were rendered using the default photobleaching
compensation function within the Volocity software package.
Semi-quantitative Analysis of Platelet Aggregates
Snapshots were generated from intravital videos and the images
corresponding to the red fluorescence channel alone (PE-
conjugated anti-CD49b) were exported as .tif documents. For
analysis of aggregate size and number, images were opened with
the ImageJ software package V1.41 (NIH at http://rsb.info.nih.
gov/ij/) and image contrast was set to maximum to sharply define
the borders of each platelet aggregate. To account for variability in
background fluorescence between experiments and between Ab
lot, and to eliminate fluorescence attributed to rapidly circulating
platelets, the minimum brightness threshold was adjusted for each
image. To determine the threshold value, LPS treated mice were
included in all experiments. Threshold values were set to yield an
average of 12–14 aggregates $50 mm
2 for all fields of view of LPS
treated animals. This number was empirically determined through
examination of fields of view from LPS treated animals and
enumeration of platelet aggregates visualized to be the size of, or
larger than neutrophils. Once the threshold value was determined
for each experiment, this value was then applied to images from all
treatment groups within the experiment, thereby allowing for
direct comparison of aggregate sizes and number between
treatment groups. Once the minimum brightness threshold was
set for each image, the number of platelet aggregates $10, 25, 50,
or 100 mm
2 were counted using the Analyze Particles function
within ImageJ.
Statistical Analysis
The number of platelet aggregates within each size category
(Fig. 2D, S5) was compared between treatment groups using a
one-way analysis of variance (ANOVA) with a Bonferroni post-test
for multi-group comparison. Untreated (n=3), LPS treated (n=5),
anti-CD18 + LPS treated (n=4), neutrophil depleted + LPS
(n=5), Kupffer cell depleted + LPS (n=4) neutrophil and Kupffer
cell depleted + LPS (n=3); a minimum of 5 fields of view were
analyzed for each animal.
Platelet counts (Fig. S2) between untreated and LPS treated
mice were compared using an unpaired Student’s t-test. Untreated
(n=5), LPS treated (n=4).
Comparisons of the number of adherent platelets, interacting
platelets (Fig. 3C), and platelets bound per neutrophil (Fig. 3D)
between untreated and LPS-treated mice were made using
unpaired Student’s t-tests. Comparison of the percentage of
neutrophils with either 0 or 3 platelets bound (Fig. 3E) in the
untreated and LPS treated groups was made using a two-way
ANOVA with a Bonferroni post-test for multi-group comparison.
Untreated (n=4), LPS treated (n=5); a minimum of 4 fields of
view were analyzed for each animal.
Comparison of the number of platelets bound to neutrophils,
KC, and sinusoids (Fig. 4C) between untreated and LPS treated
mice was made using a two-way ANOVA with a Bonferroni post-
test for multi-group comparison. Untreated (n=4), LPS treated
(n=5); a minimum of 4 fields of view were analyzed for each
animal.
Comparisons in the total area of neutrophil and Kupffer cell
staining (Fig. S7) between untreated and LPS treated mice were
made using a two-way ANOVA with a Bonferroni post-test for
multi-group comparison. Area of staining was measured in 4 mice
in each treatment group (2–4 FOV/mouse).
Supporting Information
Figure S1 Intravital visualization of platelets labelled
with PE-conjugated anti-CD49b within the mouse ear.
Spinning-disk confocal-microscopic imaging of mouse ear micro-
vasculature in untreated mice. Visualization of endothelium with
Alexa Fluor 488-conjugated anti-CD31 (i), neutrophils labelled
with Alexa Fluor 647-conjugated anti-Gr-1 (ii), platelets stained
with PE-conjugated anti-CD49b (iii), and multi-channel overlay
(iv). No adherent and few endothelial-interacting platelets were
seen in the mouse ear, a tissue visualized without surgical
intervention, under control conditions. All scale bars, 20 mm.
(TIF)
Figure S2 In vivo labelling of mouse NK cells by
intravenous injection of the anti-CD49b antibody
HMa2. Intravenous administered PE-conjugated anti-CD49b
(red) also labels NK cells in vivo (white arrow). Their larger size and
less intense staining makes labelled NK cells easily discernable
from nearby platelets (small yellow arrows). Neutrophils are
labelled with Alexa Fluor 647-conjugated anti-Gr-1 (blue); green is
liver autofluorescence to illustrate vessels. Scale bar, 20 mm.
(TIF)
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reduction in circulating platelets. Circulating platelet counts
from untreated and mice treated with 1 mg/kg LPS intravenously
for 4 h. ** p=0.01.
(TIF)
Figure S4 Flow cytometric analysis of platelets from
untreated and LPS-treated mice. Absence of neutrophil
associated (GR1) (A) or macrophage associated (F4/80) (B) surface
markers on platelets from untreated or LPS-treated mice. Staining
for CD18 expression on platelets (C, left panel) and granulocytes
(D, right panel) obtained from untreated or LPS-treated mice.
(TIF)
Figure S5 Effect of neutrophil and Kupffer cell deple-
tion on platelet aggregation in the mouse liver in
response to LPS treatment. Quantification of the number of
platelet aggregates equal to, or larger than the indicated sizes in
response to LPS treatment of wild-type mice, neutrophil depleted
mice, Kupffer cell depleted mice, and mice depleted of both
neutrophils and Kupffer cells. *** p,0.001, ** p,0.01, * p,0.05.
(TIF)
Figure S6 Circulating platelet-neutrophil aggregates.
Time lapse images of a circulating platelet-neutrophil aggregate.
The circulating neutrophil is denoted by yellow arrows and the
associated platelet aggregate is denoted by white arrows (note: the
platelet aggregates appear ahead of the neutrophil due to the
sequential capture of individual fluorescent channels). Platelets
labelled with PE-conjugated anti-CD49b (red); neutrophils
labelled with Alexa Fluor 647-conjugated anti-Gr-1 (blue); green
is liver autofluorescence to illustrate vessels. Sequential images
represent 2.3 s intervals. Scale bar, 20 mm.
(TIF)
Figure S7 Flow cytometric analysis of blood from CD41-
YFP
ki/+ mice. Representative histograms from four individual
CD41-YFP
ki/+ mice demonstrating variability in the percentage
of YFP+ platelets between animals. Histograms pre-gated on size
and for positive PE-conjugated anti-CD41 staining.
(TIF)
Figure S8 Area occupied by neutrophils and Kupffer
cells in the livers untreated and LPS-treated mice. The
area corresponding to neutrophil staining (GR1+ staining) and
Kupffer cell staining (F4/80+ staining) were measured in 12
representative fields of view (FOV) from untreated mice and mice
treated with 1 mg/kg LPS intravenously 4 h earlier. *** p,0.001,
n.s. not significant.
(TIF)
Movie S1 In vivo labelling of peripheral platelets by
intravenous injection of PE-conjugated anit-CD49b.
Intravital visualization of circulating platelets within the liver
microvasculature of an untreated C57BL/6 mouse using spinning-
disk confocal fluorescence microscopy. Platelets labelled with PE-
conjugated anti-CD49b (red); neutrophils labelled with Alexa
Fluor 647-conjugated anti-Gr-1 (blue). Objective: UPLANSAPO
106/0.40. Scale bar, 40 mm.
(MOV)
Movie S2 Platelet interactions in the liver of a control
mouse. Platelets labelled with PE-conjugated anti-CD49b can be
seen circulating through the liver sinusoids of an untreated
C57BL/6 mouse. These platelets are seen to form frequent, but
brief interactions with the sinusoid walls and few adherent
neutrophils. A small number of platelets appear to adhere to the
liver sinusoids even under control conditions. Platelets labelled
with PE-conjugated anti-CD49b (red); neutrophils labelled with
Alexa Fluor 647-conjugated anti-Gr-1 (blue). Objective: UPLAN-
SAPO 206/0.70. Scale bar, 20 mm.
(MOV)
Movie S3 Platelet behaviour in the microvasculature of
the ear in a control mouse. Although no interactions between
platelets and neutrophils are seen in the ear microvasculature of an
untreated C57BL/6 mouse, a small number of brief (touching-
down) interactions between platelets and the endothelium can be
observed. Platelets labelled with PE-conjugated anti-CD49b (red);
neutrophils labelled with Alexa Fluor 647-conjugated anti-Gr-1
(blue); endothelium labelled with Alexa Fluor 488-conjugated anti-
CD31 (green). Objective: XLUMPPlanFI 206/0.95W. Scale bar,
20 mm.
(MOV)
Movie S4 Absence of CD49b labelled platelets in a
thromboyte depleted mouse. Liver intravital microscopy in a
mouse treated for 18 h with anti-thrombocyte serum (100 ml/
mouse i.v.). Although a CD49b labelled NK cell is visible (white
arrow), there is an absence of the small adherent and circulating
CD49b+ particles confirming the identity of these objects as
platelets. NK cell and platelets labelled with PE-conjugated anti-
CD49b (red); neutrophils labelled with Alexa Fluor 647-conjugat-
ed anti-Gr-1 (blue). Objective: UPLANSAPO 206/0.70. Scale
bar, 20 mm.
(MOV)
Movie S5 Platelet interactions and adhesion within the
liver of an LPS treated mouse. Intravital visualization of a
liver from a C57BL/6 mouse 4 h after LPS treatment (1 mg/kg
i.v.). Platelets can be seen interacting with the sinusoids and
neutrophils that have been recruited to the liver, generating
dynamic aggregates and sloughing off into circulation. Platelets
labelled with PE-conjugated anti-CD49b (red); neutrophils
labelled with Alexa Fluor 647-conjugated anti-Gr-1 (blue).
Objective: UPLANSAPO 106/0.40. Scale bar, 40 mm.
(MOV)
Movie S6 4D imaging of platelet neutrophil interactions
within the liver of an LPS treated mouse. Sequential
intravital z stacks were imaged within the liver of an LPS (4 h,
1 mg/kg i.v.) treated mouse, compiled and rendered as 3D opacity
models using the Volocity software package. Platelets can be seen
to be interacting with, and adhering to neutrophils within the liver
sinusoids. Platelets were labelled with PE-conjugated anti-CD49b
(rendered red); neutrophils were labelled with Alexa Fluor 647-
conjugated anti-Gr-1 (rendered blue). Objective: UPLANSAPO
206/0.70. Grid 25.7 mm.
(MOV)
Movie S7 Dynamic platelet interactions with neutro-
phils within the liver of an LPS treated mouse. Platelet
interactions and adhesion within the liver of an LPS (4 h, 1 mg/kg
i.v.) treated C57BL/6 mouse. Platelets can be seen interacting
with, adhering to, and ‘‘flowing’’ across the surface of the
neutrophils. These platelets are also observed to from unstable
and dynamic aggregates on downstream edge of the cell before
tearing off into the circulation (white arrow). Platelets labelled with
PE-conjugated anti-CD49b (red); neutrophils labelled with Alexa
Fluor 647-conjugated anti-Gr-1 (blue). Objective: UPLANSAPO
206/0.70. Scale bar, 20 mm.
(MOV)
Movie S8 Circulating platelet-neutrophil aggregates
within the liver of an LPS treated mouse. Intravital
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treatment (1 mg/kg i.v.). Two neutrophils coated in adherent
platelets can be seen circulating through the liver microvasculature
(neutrophils enter FOV at t=4 s and t=11 s) (note: the platelet
aggregates appear ahead of the neutrophil due to the sequential
capture of individual fluorescent channels). Platelets labelled with
PE-conjugated anti-CD49b (red); neutrophils labelled with Alexa
Fluor 647-conjugated anti-Gr-1 (blue); green is liver autofluores-
cence to illustrate vessels. Objective: UPLANSAPO 206/0.70.
Scale bar, 20 mm.
(MOV)
Movie S9 Platelet behaviour within the liver of an
untreated CD41-YFP
ki/+ mouse. Intravital visualization of
the liver of an untreated CD41-YFP
ki/+ mouse. Although some
platelets are seen to interact with the liver sinusoids and
neutrophils, few adherent platelets are observed. Neutrophils
labelled with Alexa Fluor 647-conjugated anti-Gr-1 (blue); YFP+
platelets and liver autofluorescence (green). Objective: UPLAN-
SAPO 206/0.70. Scale bar, 20 mm.
(MOV)
Movie S10 Visualization of platelet adhesion in an LPS
treated CD41-YFP
ki/+ mouse. Intravital visualization of YFP+
platelets interacting with, and adhering to neutrophils within the
liver of an LPS (4 h, 1 mg/kg i.v.) treated CD41-YFP
ki/+ mouse.
Neutrophils labelled with Alexa Fluor 647-conjugated anti-Gr-1
(blue); YFP+ platelets and liver autofluorescence (green). Objec-
tive: UPLANSAPO 206/0.70. Scale bar, 20 mm.
(MOV)
Movie S11 Platelet interactions with Kupffer cells
within the liver of an LPS treated mouse. Visualization of
YFP+ platelets interacting with, and adhering to sinusoids, Kupffer
cells and neutrophils within the liver of an LPS (4 h, 1 mg/kg i.v.)
treated CD41-YFP
ki/+ mouse. Kupffer cells labelled with PE-
conjugated anti-F4/80 (red); neutrophils labelled with Alexa Fluor
647-conjugated anti-Gr-1 (blue); YFP+ platelets and liver
autofluorescence (green). Objective: UPLANSAPO 206/0.70.
Scale bar, 20 mm.
(MOV)
Movie S12 Platelet behaviour in arterioles and postcap-
illary venules of the brain in a control mouse. Intravital
visualization of an arteriole (bright CD31 staining) and postcap-
illary venule (dim CD31 staining) in the brain of an untreated
C57BL/6 mouse. No adherent neutrophils and few platelet-
endothelium interactions can be observed. Platelets labelled with
PE-conjugated anti-CD49b (red); neutrophils labelled with Alexa
Fluor 647-conjugated anti-Gr-1 (blue); endothelium labelled with
Alexa Fluor 488-conjugated anti-CD31 (green). Objective: Ob-
jective: XLUMPPlanFI 206/0.95W. Scale bar, 20 mm.
(MOV)
Movie S13 Platelet behaviour in arterioles and postcap-
illary venules of the brain in an LPS treated mouse.
Intravital visualization of an arteriole (bright CD31 staining) and
postcapillary venule (dim CD31 staining) in brain of an LPS (4 h,
1 mg/kg i.v.) treated C57BL/6 mouse. Numerous adherent
neutrophils, platelet-neutrophil, and platelet-endothelial interac-
tions can be seen within the postcapillary venule. Platelets labelled
with PE-conjugated anti-CD49b (red); neutrophils labelled with
Alexa Fluor 647-conjugated anti-Gr-1 (blue); endothelium labelled
with Alexa Fluor 488-conjugated anti-CD31 (green). Objective:
XLUMPPlanFI 206/0.95W. Scale bar, 20 mm.
(MOV)
Movie S14 Platelet behaviour in postcapillary venules of
the cremaster muscle in a control mouse. Postcapillary
venule in a C57BL/6 mouse imaged under control conditions 4 h
after local injection of the cremaster with saline. Although no
interactions between platelets and rolling, or circulating neutro-
phils are seen, some short term (touching-down) interactions of the
platelets with the endothelium can be observed. Platelets labelled
with PE-conjugated anti-CD49b (red); neutrophils labelled with
Alexa Fluor 647-conjugated anti-Gr-1 (blue); endothelium labelled
with Alexa Fluor 488-conjugated anti-CD31 (green). Objective:
UPLANFL N 106/0.30W. Scale bar, 40 mm.
(MOV)
Movie S15 Platelet-neutrophil interactions in postcap-
illary venules of the cremaster muscle after local LPS
stimulation. Postcapillary venule in a C57BL/6 mice imaged
4 h after local injection of the cremaster with LPS (0.5 mg/kg) in
saline. Platelets are seen to be adhering to, and interacting with
endothelium and both adherent and circulating neutrophils (white
arrow – appears at t=18 s). Platelets labelled with PE-conjugated
anti-CD49b (red); neutrophils labelled with Alexa Fluor 647-
conjugated anti-Gr-1 (blue); endothelium labelled with Alexa
Fluor 488-conjugated anti-CD31 (green). Objective: XLUMP-
PlanFI 206/0.95W. Scale bar, 20 mm.
(MOV)
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